Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 22 articles: HTML format Text format

Single Articles

August 2018
1. OHASHI R, Namimatsu S, Sakatani T, Naito Z, et al
   Prognostic utility of atypical mitoses in patients with breast cancer: A comparative study with Ki67 and phosphohistone H3.
   J Surg Oncol. 2018 Aug 11. doi: 10.1002/jso.25152.
   PubMed     Text format     Abstract available
   
   
   July 2018
2. SUSNIK B, Schneider L, Swenson KK, Krueger J, et al
   Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?
   J Surg Oncol. 2018;118:221-227.
   PubMed     Text format     Abstract available
   
   
   
3. YOON-FLANNERY K, DeStefano LM, De La Cruz LM, Fisher CS, et al
   Quality of life and sexual well-being after nipple sparing mastectomy: A matched comparison of patients using the breast Q.
   J Surg Oncol. 2018;118:238-242.
   PubMed     Text format     Abstract available
   
   
   
4. SMITH JR, Jaffe J, Pruitt J, Yao K, et al
   The effect of contralateral prophylactic mastectomy on breast-related charges: A 5-year analysis.
   J Surg Oncol. 2018;118:212-220.
   PubMed     Text format     Abstract available
   
   
   June 2018
5. FUJIMOTO Y, Higuchi T, Nishimukai A, Miyagawa Y, et al
   High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
   J Surg Oncol. 2018 Jun 24. doi: 10.1002/jso.25125.
   PubMed     Text format     Abstract available
   
   
   
6. ROSTAS JW, Bhutiani N, Crigger M, Crawford SMW, et al
   Calculation of breast volumes from mammogram: Comparison of four separate equations relative to mastectomy specimen volumes.
   J Surg Oncol. 2018;117:1848-1853.
   PubMed     Text format     Abstract available
   
   
   May 2018
7. SHEN S, Xu Q, Zhou Y, Mao F, et al
   Comparison of sentinel lymph node biopsy guided by blue dye with or without indocyanine green in early breast cancer.
   J Surg Oncol. 2018 May 22. doi: 10.1002/jso.25058.
   PubMed     Text format     Abstract available
   
   
   April 2018
8. VOLDERS JH, Negenborn VL, Haloua MH, Krekel NMA, et al
   Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study.
   J Surg Oncol. 2018;117:1001-1008.
   PubMed     Text format     Abstract available
   
   
   March 2018
9. ALTUNDAG K
   Breast cancer subtypes and local recurrence rate after surgery for bone metastasis to the extremities.
   J Surg Oncol. 2018 Mar 30. doi: 10.1002/jso.24987.
   PubMed     Text format    
   
   
   
10. FOSTER D, Choy N, Porter C, Ahmed S, et al
    Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    J Surg Oncol. 2018;117:336-340.
    PubMed     Text format     Abstract available
    
    
    
11. SO A, De La Cruz LM, Williams AD, Bahng J, et al
    The impact of preoperative magnetic resonance imaging and lumpectomy cavity shavings on re-excision rate in pure ductal carcinoma in situ-A single institution's experience.
    J Surg Oncol. 2018;117:558-566.
    PubMed     Text format     Abstract available
    
    
    February 2018
12. PERCY DB, Pao JS, McKevitt E, Dingee C, et al
    Number of nodes in sentinel lymph node biopsy for breast cancer: Are surgeons still biased?
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25010.
    PubMed     Text format     Abstract available
    
    
    December 2017
13. GERVAIS MK, Burtenshaw SM, Maxwell J, Dickson BC, et al
    Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challenges.
    J Surg Oncol. 2017;116:1056-1061.
    PubMed     Text format     Abstract available
    
    
    
14. GIANNINI V, Bianchi V, Carabalona S, Mazzetti S, et al
    MRI to predict nipple-areola complex (NAC) involvement: An automatic method to compute the 3D distance between the NAC and tumor.
    J Surg Oncol. 2017;116:1069-1078.
    PubMed     Text format     Abstract available
    
    
    
15. ALVARADO M, Lucci A, Manders J
    Best practices for multidisciplinary integration of a DCIS genomic assay into clinical practice.
    J Surg Oncol. 2017;116:1016-1020.
    PubMed     Text format     Abstract available
    
    
    
16. PATTEN CR, Walsh K, Sarantou T, Hadzikadic-Gusic L, et al
    Changes in margin re-excision rates: Experience incorporating the "no ink on tumor" guideline into practice.
    J Surg Oncol. 2017;116:1040-1045.
    PubMed     Text format     Abstract available
    
    
    
17. HWANG H, Park S, Koo JS, Park HS, et al
    Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast.
    J Surg Oncol. 2017;116:1046-1055.
    PubMed     Text format     Abstract available
    
    
    November 2017
18. TATARA T, Mukohara T, Shimono Y, Yamasaki T, et al
    Expression of programmed death-1 in sentinel lymph nodes of breast cancer.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24937.
    PubMed     Text format     Abstract available
    
    
    
19. ONEGA T, Weiss JE, Goodrich ME, Zhu W, et al
    Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.
    J Surg Oncol. 2017 Nov 11. doi: 10.1002/jso.24796.
    PubMed     Text format     Abstract available
    
    
    October 2017
20. LEE S, Jung Y, Bae Y
    Immediate chest wall reconstruction using an external oblique myocutaneous flap for large skin defects after mastectomy in advanced or recurrent breast cancer patients: A single center experience.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24830.
    PubMed     Text format     Abstract available
    
    
    
21. ALTUNDAG K
    Is HER2 loss after neoadjuvant chemotherapy determinant for the choice of adjuvant treatment in HER2 positive breast cancer patients?
    J Surg Oncol. 2017 Oct 2. doi: 10.1002/jso.24839.
    PubMed     Text format    
    
    
    September 2017
22. NOGUCHI M, Ohno Y, Morioka E, Noguchi M, et al
    A novel oncoplastic technique for breast cancer localized in the lower pole of the breast.
    J Surg Oncol. 2017 Sep 20. doi: 10.1002/jso.24824.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: